Should be clear from the context I was talking about the December quarter. My point is, regardless of the cap raise and additional investments it should be possible for Wayne to demonstrate that he would have achieved CF+ had we proceeded on the same path.
Happy with the narrative of needing more money to accelerate investments but I think it is incumbent on management to demonstrate that the CR was not needed to fund operational requirements for the existing portfolio.
Ann: MOU signed for Admedus Vaccines, page-78
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |